brochure

PRODUCT LINES
BROCHURE : MEPS-X series

More More
brochure

OVERVIEW
BROCHURE : MEPSGEN

More More

TECHNOLOGY

Innovative Micro & Nano Platforms for drug development

MICROPHYSIOLOGICAL SYSTEM MEPS-X series

MICROVORTEX SYSTEM MST-X series

NANOMEDICINE MG-X series

MEPS-X series

Manufactured 3D MPS Chip Platform

MST-X series

Scalable Production of Lipid Nanoparticles

MG-X series

Nanoparticle Drug Delivery System

MEDIA

MEPSGEN plans to IPO in 2025
MEPSGEN plans to IPO in 2025
2023.09.27
MEPS-AMS is the answer to the rapid advancement of MPS
MEPS-AMS is the answer to the rapid advancement of MPS
2023.09.26
MEPSGEN's expertise in both MPS and nanoparticle technologies
MEPSGEN's expertise in both MPS and nanoparticle technologies
2023.09.25
Korea should kick off national-level project to end animal-testing
Korea should kick off national-level project to end animal-testing
2023.09.19
South Korea's national assembly must pass the VAAM act to become a first mover
South Korea's national assembly must pass the VAAM act to become a first mover
2023.09.18
MEPSGEN's MPS chip will lead the global drug evaluation platform market
MEPSGEN's MPS chip will lead the global drug evaluation platform market
2023.09.08
To network with amazing people at KAATC
To network with amazing people at KAATC
2023.09.07
Which non-clinical platform will fill the gap?
Which non-clinical platform will fill the gap?
2023.08.09
CEO YongTae Kim shares his thoughts on how blood-brain-barrier-on-a-chip could improve the drug development process
CEO YongTae Kim shares his thoughts on how blood-brain-barrier-on-a-chip could improve the drug development process
2023.08.02

Sitemap닫기

PRODUCT
MEPS-X
MST-X
PIPELINE
MG-X
TECHNOLOGY
MICROPHYSIOLOGICAL SYSTEMS (MPS)
MICROVORTEX SYSTEM
NANOMEDICINE
SERVICE
SERVICE
ABOUT
OVERVIEW
VISION
HISTORY
ORGANIZATION
CI
OVERSEAS
CONTACT
NEWS
NOTICE
MEDIA
ARTICLE
CAREERS
CULTURE
HIRING
PROCESS
WE'RE HIRING!